Castleark Management LLC Dexcom Inc Transaction History

Castleark Management LLC

$2.41 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $626,560 - $797,755	5,680 Added 1.31%	438,078 $49.7 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $656,650 - $805,434	-5,749 Reduced 1.31%	432,398 $60 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $974,047 - $1.6 Million	-12,903 Reduced 2.86%	438,147 $54.4 Million
Q3 2023 Nov 15, 2023	SELL	$86.06 - $137.93 $191,913 - $307,583	-2,230 Reduced 0.49%	451,050 $42.1 Million
Q2 2023 Aug 15, 2023	BUY	$112.47 - $130.98 $127,091 - $148,007	1,130 Added 0.25%	453,280 $58.3 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $5.25 Million - $6.21 Million	50,520 Added 12.58%	452,150 $52.5 Million
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $22.5 Million - $32.5 Million	264,590 Added 193.08%	401,630 $45.5 Million
Q3 2022 Nov 15, 2022	SELL	$76.35 - $94.18 $4.18 Million - $5.15 Million	-54,700 Reduced 28.53%	137,040 $11 Million
Q2 2022 Aug 16, 2022	BUY	$67.99 - $132.89 $8.91 Million - $17.4 Million	131,005 Added 215.7%	191,740 $14.3 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $114,777 - $158,844	1,220 Added 2.05%	60,735 $31.1 Million
Q4 2021 Feb 16, 2022	BUY	$129.87 - $162.82 $61,038 - $76,525	470 Added 0.8%	59,515 $32 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $102,975 - $138,168	965 Added 1.66%	59,045 $32.3 Million
Q2 2021 Aug 17, 2021	SELL	$80.99 - $107.93 $42,114 - $56,123	-520 Reduced 0.89%	58,080 $24.8 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $132,696 - $163,918	-1,565 Reduced 2.6%	58,600 $21.1 Million
Q4 2020 Feb 17, 2021	SELL	$78.0 - $104.5 $120,510 - $161,452	-1,545 Reduced 2.5%	60,165 $22.2 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $914,508 - $1.08 Million	-9,575 Reduced 13.43%	61,710 $25.4 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $2.29 Million - $3.85 Million	-36,585 Reduced 33.92%	71,285 $28.9 Million
Q1 2020 May 13, 2020	BUY	$47.79 - $75.63 $3.36 Million - $5.33 Million	70,410 Added 187.96%	107,870 $29 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $2.08 Million - $3.26 Million	-56,880 Reduced 60.29%	37,460 $8.19 Million
Q3 2019 Nov 15, 2019	SELL	$35.53 - $43.8 $215,560 - $265,734	-6,067 Reduced 6.04%	94,340 $14.1 Million
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $644,078 - $900,414	-23,135 Reduced 18.73%	100,407 $15 Million
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $1.34 Million - $1.82 Million	-47,566 Reduced 27.8%	123,542 $14.7 Million
Q4 2018 Feb 12, 2019	SELL	$26.99 - $37.37 $1.16 Million - $1.6 Million	-42,845 Reduced 20.03%	171,108 $20.5 Million
Q3 2018 Nov 15, 2018	BUY	$23.35 - $36.72 $1.56 Million - $2.46 Million	66,902 Added 45.5%	213,953 $30.6 Million
Q2 2018 Aug 15, 2018	BUY	$17.54 - $25.22 $2.58 Million - $3.71 Million	147,051 New	147,051 $14 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Account